newsfilter
← Latest News
PR Newswire·

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

  • VolitionRx Limited & Fujifilm Vet Systems completed validation of the chemiluminescent immunoassay version of the Nu.Q® Vet Cancer Test in Japan.
  • The validation enables full automation using the IDS i10® analyzer platform, replacing previous manual plate methods.
  • Over 1,700 veterinary hospitals in Japan are already registered to use the test since its July 2024 launch.
  • The automation allows for rapid turnaround times & high throughput to meet increasing demand.
  • The automated platform matches the technology used for Volition's human products, including Nu.Q® Cancer, Nu.Q® NETs, & Nu.Q® Discover.
  • Fujifilm Vet Systems will distribute & perform the test throughout its network of central reference laboratories across Japan.
  • Volition aims to capitalize on the market of approximately seven million pet dogs in Japan to improve early cancer detection outcomes.